Clinical Rheumatology

, Volume 34, Issue 2, pp 301–306 | Cite as

C-reactive protein gene and Toll-like receptor 4 gene polymorphisms can relate to the development of psoriatic arthritis

  • Ayla Akbal
  • Sevilay Oğuz
  • Ferhat Gökmen
  • Serhat Bilim
  • Hatice Reşorlu
  • Fatma Sılan
  • Ahmet Uludağ
Original Article

Abstract

We aimed to determine in psoriatic arthritis (PsA) patients the Toll-like receptor (TLR) 4 and C-reactive gene (CRP) polymorphisms and allele frequency and to investigate the relationship between clinical parameters and gene polymorphisms. We enrolled in this study 31 PsA and 41 healthy control subjects. PsA diagnosis was according to CASPAR criteria. Bath ankylosing spondylitis diseases activity index, Maastricht ankylosing spondylitis enthesitis score, and Bath ankylosing spondylitis functional index were measured. C, A, and T alleles of CRP and A and G alleles of TLR 4 were determined using the analysis of melting curves after real-time PCR. CRP A, C, and T allele frequency in controls was 26.8, 73.2, and 36.6 %, respectively. In the PsA patient group, A, C, and T allele frequency was 9.7, 87.1, and 12.9 %, respectively. Between control and PsA groups, there was a significant difference in A, C, and T allele frequency (P = 0.008, 0.038, and 0.001, respectively). The frequency of CRP gene polymorphisms (CA, AA, CT, TA, and TT alleles) in the control group was 56.1 % and in the PsA group was 22.6 %. There was a significant difference between the two groups (P = 0.004). The absence of a CRP gene polymorphism was a risk factor for PsA (odds ratio 4.3, 95 % CI; 1.5–12.4, P = 0.005). TLR gene haploid frequency was investigated, and all control subjects had the wild-type AA allele. PsA patient GA allele frequency was 6.5 %. There was no significant difference between the two groups (P = 0.182). GA mutant allele frequency was related to PsA (odds ratio 7.03, 95 % CI; 0.32–151.9, P = 0.214). We have shown that CRP gene polymorphisms are higher in control subjects than PsA patients, and TLR 4 gene polymorphisms were found to be related to PsA.

Keywords

C-reactive gene Polymorphisms Psoriatic arthritis Toll-like receptor 4 

References

  1. 1.
    Mease P (2013) Psoriatic arthritis and spondyloarthritis assessment and management update. Curr Opin Rheumatol 25:287–296. doi:10.1097/BOR.0b013e32835fd8d5 PubMedCrossRefGoogle Scholar
  2. 2.
    Villanova F, Di Meglio P, Nestle FO (2013) Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis 72(Suppl 2):ii104-10. doi:10.1136/annrheumdis-2012-203037 PubMedGoogle Scholar
  3. 3.
    Benham H, Norris P, Goodall J et al (2013) Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 15:R136. doi:10.1186/ar4317 PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Genetic Képíró L, Széll M, Kovács L, Keszthelyi P, Kemény L, Gyulai R (2014) Risk and protective factors of TNFSF15 gene variants detected using single nucleotide polymorphisms in Hungarians with psoriasis and psoriatic arthritis. Hum Immunol 75:159–162. doi:10.1016/j.humimm.2013.11.006 CrossRefGoogle Scholar
  5. 5.
    Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI (2013) The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol 2013:569751. doi:10.1155/2013/569751 PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    O’Donnell H, Pham OH, Li LX et al (2014) Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 40:213–224. doi:10.1016/j.immuni.2013.12.013 PubMedCrossRefGoogle Scholar
  7. 7.
    Peng L, Luo YT, Liu JL (2011) The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte. Zhonghua Xin Xue Guan Bing Za Zhi 39:664–669PubMedGoogle Scholar
  8. 8.
    Liu N, Liu JT, Ji YY, Lu PP (2010) C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells. Life Sci 87:367–374. doi:10.1016/j.lfs.2010.07.012 PubMedCrossRefGoogle Scholar
  9. 9.
    Carrasco S, Neves FS, Fonseca MH et al (2011) Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger? Clin Exp Rheumatol 29:958–962PubMedGoogle Scholar
  10. 10.
    Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR (2007) Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients psoriatic arthritis: a pathogenic role for innate immunity? J Rheumatol 3:374–379Google Scholar
  11. 11.
    Garcia-Rodriguez S, Arias-Santiago S, Perandrés-López R et al (2013) Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J Eur Acad Dermatol Venereol 27:242–250PubMedCrossRefGoogle Scholar
  12. 12.
    Garcia-Rodriguez S, Arias-Santiago S, Perandrés-López R et al (2011) Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J Eur Acad Dermatol Venereol. doi:10.1111/j.1468-3083.2011.04372.x PubMedGoogle Scholar
  13. 13.
    Bogaczewicz A, Sobow T, Bogaczewicz J et al (2013) Toll-like receptor 4 gene polymorphism 1196C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population—a preliminary report. Lupus 22:1504–1508. doi:10.1177/0961203313511553 PubMedCrossRefGoogle Scholar
  14. 14.
    Yang H, Wei C, Li Q et al (2013) Association of TLR4 gene non-missense single nucleotide polymorphisms with rheumatoid arthritis in Chinese Han population. Rheumatol Int 33:1283–1288. doi:10.1007/s00296-012-2536-8 PubMedCrossRefGoogle Scholar
  15. 15.
    Xu WD, Liu SS, Pan HF, Ye DQ (2012) Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. Joint Bone Spine 79:566–569. doi:10.1016/j.jbspin.2012.02.012 PubMedCrossRefGoogle Scholar
  16. 16.
    Myles A, Aggarwal A (2013) Lack of association of single nucleotide polymorphisms in toll-like receptors 2 and 4 with enthesitis-related arthritis category of juvenile idiopathic arthritis in Indian population. Rheumatol Int 33:417–421PubMedCrossRefGoogle Scholar
  17. 17.
    García-Bermúdez M, López-Mejías R, González-Juanatey C et al (2012) Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol 31:1214–1220. doi:10.1089/dna.2011 PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Hernesniemi JA, Raitakari OT, Kähönen M et al (2008) Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 198:152–159PubMedCrossRefGoogle Scholar
  19. 19.
    Lamb R, Zeggini E, Thomson W, Donn R (2005) Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Ann Rheum Dis 64(5):767–769PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Beygi S, Lajevardi V, Abedini R (2013) C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.12257 PubMedGoogle Scholar
  21. 21.
    Abd El-Aziz TA, Mohamed RH (2013) Human C-reactive protein gene polymorphism and metabolic syndrome are associated with premature coronary artery disease. Gene 532:216–221. doi:10.1016/j.gene.2013.09.042 PubMedCrossRefGoogle Scholar
  22. 22.
    Martínez-Calleja A, Quiróz-Vargas I, Parra-Rojas I, et al (2012) Haplotypes in the CRP gene associated with increased BMI and levels of CRP in subjects with type 2 diabetes or obesity from Southwestern Mexico. Exp Diabetes Res 982683. doi:10.1155/2012/982683
  23. 23.
    Shen C, Sun X, Wang H et al (2013) Association study of CRP gene and ischemic stroke in a Chinese Han population. J Mol Neurosci 49:559–566. doi:10.1007/s12031-012-9856-8 PubMedCrossRefGoogle Scholar
  24. 24.
    Kim HA, Chun HY, Kim SH, Park HS, Suh CH (2009) C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosus. J Rheumatol 36(10):2238–2243. doi:10.3899/jrheum.090243 PubMedCrossRefGoogle Scholar
  25. 25.
    Almeida OP, Norman PE, Allcock R et al (2009) Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 38:1049–1059. doi:10.1093/ije/dyp199 PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Lawlor DA, Harbord RM, Timpson NJ et al (2008) The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS One 3:e3011. doi:10.1371/journal.pone.0003011 PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Chang YC, Wu WM, Hsu LA (2012) Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese. Mol Biol Rep 39:4111–4117. doi:10.1007/s11033-011-1193-4 PubMedCrossRefGoogle Scholar
  28. 28.
    Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRefGoogle Scholar
  29. 29.
    Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedCrossRefGoogle Scholar
  30. 30.
    Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–284PubMedCrossRefGoogle Scholar
  31. 31.
    Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127–132PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Jenkinson TR, Mallorie P, Whitelock HC, Kennedy LG, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrological Index (BASMI). J Rheumatol 21:1694–1698PubMedGoogle Scholar
  33. 33.
    Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E (2005) The Turkish version of Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24:123–128PubMedCrossRefGoogle Scholar
  34. 34.
    Jönsen A, Gunnarsson I, Gullstrand B et al (2007) Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford) 46:1417–1421CrossRefGoogle Scholar
  35. 35.
    Szalai AJ, Alarcón GS, Calvo-Alén J et al (2005) Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology (Oxford) 44:864–868CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2014

Authors and Affiliations

  • Ayla Akbal
    • 1
    • 4
  • Sevilay Oğuz
    • 2
    • 4
  • Ferhat Gökmen
    • 1
    • 4
  • Serhat Bilim
    • 1
    • 4
  • Hatice Reşorlu
    • 1
    • 4
  • Fatma Sılan
    • 3
    • 4
  • Ahmet Uludağ
    • 3
    • 4
  1. 1.Department of Physical Medicine and RehabilitationÇanakkale Onsekiz Mart UniversityÇanakkaleTurkey
  2. 2.Department of DermatologyÇanakkale Onsekiz Mart UniversityÇanakkaleTurkey
  3. 3.Department of Medical GeneticÇanakkale Onsekiz Mart UniversityÇanakkaleTurkey
  4. 4.Faculty of MedicibeÇanakkale Onsekiz Mart UniversityÇanakkaleTurkey

Personalised recommendations